Cargando…
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment
BACKGROUND: Current risk stratification systems for neuroblastoma patients consider clinical, histopathological, and genetic variables, and additional prognostic markers have been proposed in recent years. We here sought to select highly informative covariates in a multistep strategy based on consec...
Autores principales: | Rosswog, Carolina, Schmidt, Rene, Oberthuer, André, Juraeva, Dilafruz, Brors, Benedikt, Engesser, Anne, Kahlert, Yvonne, Volland, Ruth, Bartenhagen, Christoph, Simon, Thorsten, Berthold, Frank, Hero, Barbara, Faldum, Andreas, Fischer, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678736/ https://www.ncbi.nlm.nih.gov/pubmed/29091799 http://dx.doi.org/10.1016/j.neo.2017.09.006 |
Ejemplares similares
-
MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma
por: Lau, Diana T., et al.
Publicado: (2015) -
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification
por: Berthold, Frank, et al.
Publicado: (2021) -
Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma
por: Kocak, H, et al.
Publicado: (2013) -
Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas
por: Westermann, Frank, et al.
Publicado: (2008) -
Reliable assessment of telomere maintenance mechanisms in neuroblastoma
por: Meeser, Alina, et al.
Publicado: (2022)